Reaction profile

The FDA adverse-event record for focusing difficult

39 FDA reports name focusing difficult, a lower-volume reaction in the CVM extract (VeDDRA 1479). Plate stamps and neighbourhood peers follow.

#1860 of 2,481
by report volume (all reactions)
39
reports citing this reaction
5.1%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Focusing difficult has 39 reports now versus 39 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Focusing difficult changes

FDA AER · VeDDRA plate

Code 1479 VOL-TRACE

VOL-TRACE · DEATH-PAR · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 39 reports
  • DEATH-PAR 5.1%
  • MID-PACK #1860/2481
  • PHOTO-FINISH Adaptor, missing
  • SPECIES-DOG Dog · 33
  • DRUG-LEAD Milbemycin Oxime… · 10
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Adaptor, missing (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Focusing difficult

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Adaptor, missing · near39Adrenal gland tumour · near39Cardiopathy · near39CAT SCAN ABNORMAL · near39Focusing difficult · this re…39Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Focusing difficult

Focusing difficult: low death-coded share in the FDA AER plate

Signature read: 2 death-coded reports is a thin tail count for Focusing difficult in the CVM extract. Report volume is lower-third scale: 39 named reports in the openFDA extract. Death-coded share is lower-third: 2 of 39 reports (5.1% of named reports). Nearest volume peer: Adaptor, missing (±0 reports). Lead species Dog (33). Lead co-reported drug Milbemycin Oxime + Spinosad (10).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Milbemycin Oxime + Spinosad appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 33
Cat 4
Horse 1
Human 1

Breeds Most Affected

Retriever - Labrador 6
Chihuahua 4
Shepherd Dog - German 2
Pointing Dog - Hungarian Short-haired (Vizsla) 2
Crossbred Canine/dog 2
Beagle 2
Corgi (unspecified) 1
Spitz - German Pomeranian 1
Bulldog - American 1
Poodle - Miniature 1

Associated Drugs

Milbemycin Oxime + Spinosad 10
Sarolaner 5
Bedinvetmab 5
Afoxolaner 4
Oclacitinib Maleate 3
Diphenhydramine 2
Meloxicam 2
Imidacloprid + Moxidectin 2
Fluralaner Chew Tablets 2
Pimobendan 2
Ivermectin + Pyrantel 2
Distemper Vaccine 1
Lepto Vaccine 1
Amoxicillin As Trihydrate 1
Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 1
Leptospira Canicola L-15 Strain C-51; Leptospira Grippotyphosa 1550 Lot 10005 St 1
Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St 1
Diphenhydramine Hcl 1
Dexamethasone Sodium Phosphate 1
Famotidine 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Focusing difficult (#1860 of 2,481 by report volume); death-coded 5.1%. PlainBreed reaction plate · death-coded report count stamp 2 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →